Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade

Free Radical Biology and Medicine

Volumn 52, Issue 3, 2012, Pages 593-600

  Belkacemi, Abdenour ^a   Ramassamy, Charles ^a,b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Antioxidants; Free radicals; Lipid peroxidation; Neurofibrillary tangles; Presenilins; Protein carbonyls; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; FREE RADICAL; PRESENILIN; SUPEROXIDE DISMUTASE; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN DAMAGE; COGNITIVE DEFECT; ENZYME ACTIVITY; GENE MUTATION; GENE OVEREXPRESSION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRESENILINS; TAU PROTEINS; TIME FACTORS;

MUS; MUS MUSCULUS;

EID: 84856297340     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.11.020     Document Type: Review

References (67)

1. L. Bertram, C.M. Lill, and R.E. Tanzi The genetics of Alzheimer disease: back to the future Neuron 68 2010 270 281
2. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population: prevalence estimates using the 2000 census Arch. Neurol. 60 2003 1119 1122 (Pubitemid 36975801)
3. J. Poirier, J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand, and S. Gauthier Apolipoprotein E polymorphism and Alzheimer's disease Lancet 342 1993 697 699 (Pubitemid 23279761)
4. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
5. N. Sawamura, M. Morishima-Kawashima, H. Waki, K. Kobayashi, T. Kuramochi, M.P. Frosch, K. Ding, M. Ito, T.W. Kim, R.E. Tanzi, F. Oyama, T. Tabira, S. Ando, and Y. Ihara Mutant presenilin 2 transgenic mice: a large increase in the levels of Abeta 42 is presumably associated with the low density membrane domain that contains decreased levels of glycerophospholipids and sphingomyelin J. Biol. Chem. 275 2000 27901 27908
6. E. Tamagno, M. Parola, P. Bardini, A. Piccini, R. Borghi, M. Guglielmotto, G. Santoro, A. Davit, O. Danni, M.A. Smith, G. Perry, and M. Tabaton Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways J. Neurochem. 92 2005 628 636 (Pubitemid 40189465)
7. M.A. Lovell, S. Xiong, C. Xie, P. Davies, and W.R. Markesbery Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3 J. Alzheimers Dis. 6 2004 659 671 discussion 673-681 (Pubitemid 40164172)
8. B.J. Tabner, O.M. El-Agnaf, S. Turnbull, M.J. German, K.E. Paleologou, Y. Hayashi, L.J. Cooper, N.J. Fullwood, and D. Allsop Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia J. Biol. Chem. 280 2005 35789 35792 (Pubitemid 41633844)
9. M. Singh, D.T. Nam, M. Arseneault, and C. Ramassamy Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein J. Alzheimers Dis. 21 2010 741 756
10. D.A. Butterfield, T. Reed, and R. Sultana Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease Free Radic. Res. 45 2011 59 72
11. M.A. Lovell, and W.R. Markesbery Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease Nucleic Acids Res. 35 2007 7497 7504
12. M.A. Lovell, and W.R. Markesbery Oxidatively modified RNA in mild cognitive impairment Neurobiol. Dis. 29 2008 169 175
13. I. Baldeiras, I. Santana, M.T. Proenca, M.H. Garrucho, R. Pascoal, A. Rodrigues, D. Duro, and C.R. Oliveira Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment J. Alzheimers Dis. 21 2010 1165 1177
14. M.A. Lovell, and W.R. Markesbery Oxidative damage in mild cognitive impairment and early Alzheimer's disease J. Neurosci. Res. 85 2007 3036 3040 (Pubitemid 350057358)
15. A. Nunomura, R.J. Castellani, X. Zhu, P.I. Moreira, G. Perry, and M.A. Smith Involvement of oxidative stress in Alzheimer disease J. Neuropathol. Exp. Neurol. 65 2006 631 641 (Pubitemid 44297254)
16. K.H. Park, J.L. Hallows, P. Chakrabarty, P. Davies, and I. Vincent Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice J. Neurosci. 27 2007 2969 2978 (Pubitemid 46438995)
17. C. Duyckaerts, M.C. Potier, and B. Delatour Alzheimer disease models and human neuropathology: similarities and differences Acta Neuropathol. 115 2008 5 38 (Pubitemid 50005258)
18. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102 (Pubitemid 26332733)
19. J. Apelt, M. Bigl, P. Wunderlich, and R. Schliebs Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology Int. J. Dev. Neurosci. 22 2004 475 484 (Pubitemid 39311436)
20. A. Cimini, S. Moreno, M. D'Amelio, L. Cristiano, B. D'Angelo, S. Falone, E. Benedetti, P. Carrara, F. Fanelli, F. Cecconi, F. Amicarelli, and M.P. Ceru Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes J. Alzheimers Dis. 18 2009 935 952
21. D. Pratico, K. Uryu, S. Leight, J.Q. Trojanoswki, and V.M. Lee Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J. Neurosci. 21 2001 4183 4187 (Pubitemid 32538543)
22. S. Melov, P.A. Adlard, K. Morten, F. Johnson, T.R. Golden, D. Hinerfeld, B. Schilling, C. Mavros, C.L. Masters, I. Volitakis, Q.X. Li, K. Laughton, A. Hubbard, R.A. Cherny, B. Gibson, and A.I. Bush Mitochondrial oxidative stress causes hyperphosphorylation of tau PLoS One 2 2007 e536
23. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson, and F. Gillespie Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein Nature 373 1995 523 527
24. J.F. Reilly, D. Games, R.E. Rydel, S. Freedman, D. Schenk, W.G. Young, J.H. Morrison, and F.E. Bloom Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model Proc. Natl. Acad. Sci. U. S. A. 100 2003 4837 4842 (Pubitemid 36457815)
25. G. Chen, K.S. Chen, J. Knox, J. Inglis, A. Bernard, S.J. Martin, A. Justice, L. McConlogue, D. Games, S.B. Freedman, and R.G. Morris A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease Nature 408 2000 975 979 (Pubitemid 32101643)
26. J.C. Dodart, C. Mathis, J. Saura, K.R. Bales, S.M. Paul, and A. Ungerer Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice Neurobiol. Dis. 7 2000 71 85 (Pubitemid 30241204)
27. H. Du, L. Guo, S. Yan, A.A. Sosunov, G.M. McKhann, and S.S. Yan Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model Proc. Natl. Acad. Sci. U. S. A. 107 2010 18670 18675
28. J. Yao, H. Du, S. Yan, F. Fang, C. Wang, L.F. Lue, L. Guo, D. Chen, D.M. Stern, F.J. Gunn Moore, J. Xi Chen, O. Arancio, and S.S. Yan Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease J. Neurosci. 31 2011 2313 2320
29. D.A. Butterfield, V. Galvan, M.B. Lange, H. Tang, R.A. Sowell, P. Spilman, J. Fombonne, O. Gorostiza, J. Zhang, R. Sultana, and D.E. Bredesen In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid β-peptide of APP Free Radic. Biol. Med. 48 2010 136 144
30. V. Blanchard, S. Moussaoui, C. Czech, N. Touchet, B. Bonici, M. Planche, T. Canton, I. Jedidi, M. Gohin, O. Wirths, T.A. Bayer, D. Langui, C. Duyckaerts, G. Tremp, and L. Pradier Time sequence of maturation of dystrophic neurites associated with A β deposits in APP/PS1 transgenic mice Exp. Neurol. 184 2003 247 263 (Pubitemid 37444035)
31. K. Schuessel, S. Schafer, T.A. Bayer, C. Czech, L. Pradier, F. Muller-Spahn, W.E. Muller, and A. Eckert Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice Neurobiol. Dis. 18 2005 89 99 (Pubitemid 40092899)
32. M.A. Chishti, D.S. Yang, C. Janus, A.L. Phinney, P. Horne, J. Pearson, R. Strome, N. Zuker, J. Loukides, J. French, S. Turner, G. Lozza, M. Grilli, S. Kunicki, C. Morissette, J. Paquette, F. Gervais, C. Bergeron, P.E. Fraser, G.A. Carlson, P.S. George-Hyslop, and D. Westaway Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 J. Biol. Chem. 276 2001 21562 21570 (Pubitemid 37413154)
33. N. Brouwers, K. Sleegers, and C. Van Broeckhoven Molecular genetics of Alzheimer's disease: an update Ann. Med. 40 2008 562 583
34. B. De Strooper Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex Neuron 38 2003 9 12 (Pubitemid 36423348)
35. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, and S. Younkin Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Nat. Med. 2 1996 864 870 (Pubitemid 26296755)
36. K. Duff, C. Eckman, C. Zehr, X. Yu, C.M. Prada, J. Perez-tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, D. Morgan, M.N. Gordon, L. Holcomb, L. Refolo, B. Zenk, J. Hardy, and S. Younkin Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1 Nature 383 1996 710 713 (Pubitemid 26360645)
37. D.R. Borchelt, G. Thinakaran, C.B. Eckman, M.K. Lee, F. Davenport, T. Ratovitsky, C.M. Prada, G. Kim, S. Seekins, D. Yager, H.H. Slunt, R. Wang, M. Seeger, A.I. Levey, S.E. Gandy, N.G. Copeland, N.A. Jenkins, D.L. Price, S.G. Younkin, and S.S. Sisodia Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo Neuron 17 1996 1005 1013 (Pubitemid 26424026)
38. C.A. Lemere, F. Lopera, K.S. Kosik, C.L. Lendon, J. Ossa, T.C. Saido, H. Yamaguchi, A. Ruiz, A. Martinez, L. Madrigal, L. Hincapie, J.C. Arango, D.C. Anthony, E.H. Koo, A.M. Goate, and D.J. Selkoe The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology Nat. Med. 2 1996 1146 1150 (Pubitemid 26338637)
39. M. Citron, D. Westaway, W. Xia, G. Carlson, T. Diehl, G. Levesque, K. Johnson-Wood, M. Lee, P. Seubert, A. Davis, D. Kholodenko, R. Motter, R. Sherrington, B. Perry, H. Yao, R. Strome, I. Lieberburg, J. Rommens, S. Kim, D. Schenk, P. Fraser, P. St George Hyslop, and D.J. Selkoe Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice Nat. Med. 3 1997 67 72 (Pubitemid 27019143)
40. M. Duering, M.O. Grimm, H.S. Grimm, J. Schroder, and T. Hartmann Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42 Neurobiol. Aging 26 2005 785 788 (Pubitemid 40249479)
41. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, G. Li, K. Holman, T. Tsuda, L. Mar, J.F. Foncin, A.C. Bruni, M.P. Montesi, S. Sorbi, I. Rainero, L. Pinessi, L. Nee, I. Chumakov, D. Pollen, A. Brookes, P. Sanseau, R.J. Polinsky, W. Wasco, H.A. Da Silva, J.L. Haines, M.A. Perkicak-Vance, R.E. Tanzi, A.D. Roses, P.E. Fraser, J.M. Rommens, and P.H. St George-Hyslop Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
42. M. Haltia, M. Viitanen, R. Sulkava, V. Ala-Hurula, M. Poyhonen, L. Goldfarb, P. Brown, E. Levy, H. Houlden, and R. Crook Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description Ann. Neurol. 36 1994 362 367 (Pubitemid 24280057)
43. D.G. Flood, A.G. Reaume, K.S. Dorfman, Y.G. Lin, D.M. Lang, S.P. Trusko, M.J. Savage, W.G. Annaert, B. De Strooper, R. Siman, and R.W. Scott FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction Neurobiol. Aging 23 2002 335 348 (Pubitemid 34312016)
44. K. Tanemura, D.H. Chui, T. Fukuda, M. Murayama, J.M. Park, T. Akagi, Y. Tatebayashi, T. Miyasaka, T. Kimura, T. Hashikawa, Y. Nakano, T. Kudo, M. Takeda, and A. Takashima Formation of tau inclusions in knock-in mice with familial Alzheimer disease (FAD) mutation of presenilin 1 (PS1) J. Biol. Chem. 281 2006 5037 5041 (Pubitemid 43847768)
45. K. Schuessel, C. Frey, C. Jourdan, U. Keil, C.C. Weber, F. Muller-Spahn, W.E. Muller, and A. Eckert Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice Free Radic. Biol. Med. 40 2006 850 862 (Pubitemid 43327319)
46. M.A. LaFontaine, M.P. Mattson, and D.A. Butterfield Oxidative stress in synaptosomal proteins from mutant presenilin-1 knock-in mice: implications for familial Alzheimer's disease Neurochem. Res. 27 2002 417 421 (Pubitemid 34579349)
47. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen, and M.A. Smith Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 60 2001 759 767 (Pubitemid 32678256)
48. M.P. Cuajungco, L.E. Goldstein, A. Nunomura, M.A. Smith, J.T. Lim, C.S. Atwood, X. Huang, Y.W. Farrag, G. Perry, and A.I. Bush Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc J. Biol. Chem. 275 2000 19439 19442 (Pubitemid 30441532)
49. J.G. Begley, W. Duan, S. Chan, K. Duff, and M.P. Mattson Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice J. Neurochem. 72 1999 1030 1039 (Pubitemid 29085017)
50. A.G. Reaume, D.S. Howland, S.P. Trusko, M.J. Savage, D.M. Lang, B.D. Greenberg, R. Siman, and R.W. Scott Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" Abeta sequence J. Biol. Chem. 271 1996 23380 23388 (Pubitemid 26314785)
51. R. Siman, A.G. Reaume, M.J. Savage, S. Trusko, Y.G. Lin, R.W. Scott, and D.G. Flood Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability J. Neurosci. 20 2000 8717 8726
52. M. Anantharaman, J. Tangpong, J.N. Keller, M.P. Murphy, W.R. Markesbery, K.K. Kiningham, and D.K. St Clair Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease Am. J. Pathol. 168 2006 1608 1618
53. Q. Huang, C.D. Aluise, G. Joshi, R. Sultana, D.K. St Clair, W.R. Markesbery, and D.A. Butterfield Potential in vivo amelioration by N-acetyl-l-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment J. Neurosci. Res. 88 2010 2618 2629
54. H.M. Abdul, R. Sultana, D.K. St Clair, W.R. Markesbery, and D.A. Butterfield Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age Free Radic. Biol. Med. 45 2008 1420 1425
55. K. Kanninen, T.M. Malm, H.K. Jyrkkanen, G. Goldsteins, V. Keksa-Goldsteine, H. Tanila, M. Yamamoto, S. Yla-Herttuala, A.L. Levonen, and J. Koistinaho Nuclear factor erythroid 2-related factor 2 protects against beta amyloid Mol. Cell. Neurosci. 39 2008 302 313
56. D.R. Howlett, J.C. Richardson, A. Austin, A.A. Parsons, S.T. Bate, D.C. Davies, and M.I. Gonzalez Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes Brain Res. 1017 2004 130 136 (Pubitemid 38917152)
57. J.C. Richardson, C.E. Kendal, R. Anderson, F. Priest, E. Gower, P. Soden, R. Gray, S. Topps, D.R. Howlett, D. Lavender, N.J. Clarke, J.C. Barnes, R. Haworth, M.G. Stewart, and H.T. Rupniak Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease Neuroscience 122 2003 213 228 (Pubitemid 37329960)
58. Choudhry, F.; Howlett, D.R.; Richardson, J.C.; Francis, P.T.; Williams, R.J.; Pro-oxidant diet enhances beta/gamma secretase-mediated APP processing in APP/PS1 transgenic mice. Neurobiol. Aging; in press.
59. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421 (Pubitemid 36937044)
60. S. Oddo, A. Caccamo, M. Kitazawa, B.P. Tseng, and F.M. LaFerla Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease Neurobiol. Aging 24 2003 1063 1070 (Pubitemid 37487883)
61. L.M. Billings, S. Oddo, K.N. Green, J.L. McGaugh, and F.M. LaFerla Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice Neuron 45 2005 675 688 (Pubitemid 40320703)
62. J.P. Blass, R.K. Sheu, and G.E. Gibson Inherent abnormalities in energy metabolism in Alzheimer disease: interaction with cerebrovascular compromise Ann. N. Y. Acad. Sci. 903 2000 204 221 (Pubitemid 30251560)
63. J. Yao, R.W. Irwin, L. Zhao, J. Nilsen, R.T. Hamilton, and R.D. Brinton Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 106 2009 14670 14675
64. S.D. Yan, and D.M. Stern Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD) Int. J. Exp. Pathol. 86 2005 161 171 (Pubitemid 40813912)
65. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan, and H. Wu ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452 (Pubitemid 38495942)
66. J.L. Chou, D.V. Shenoy, N. Thomas, P.K. Choudhary, F.M. Laferla, S.R. Goodman, and G.A. Breen Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease J. Proteomics 74 2011 466 479
67. R. Resende, P.I. Moreira, T. Proenca, A. Deshpande, J. Busciglio, C. Pereira, and C.R. Oliveira Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease Free Radic. Biol. Med. 44 2008 2051 2057